341 related articles for article (PubMed ID: 29958877)
1. Canadian physician survey on the medical management of hereditary angioedema.
Fu L; Kanani A; Lacuesta G; Waserman S; Betschel S
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):598-603. PubMed ID: 29958877
[TBL] [Abstract][Full Text] [Related]
2. Current medical management of hereditary angioedema: follow-up survey of US physicians.
Riedl MA; Banerji A; Gower R
J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
[TBL] [Abstract][Full Text] [Related]
3. Current medical management of hereditary angioedema: Follow-up survey of US physicians.
Riedl MA; Banerji A; Gower R
Ann Allergy Asthma Immunol; 2021 Mar; 126(3):264-272. PubMed ID: 33122123
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
5. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
Lunn ML; Santos CB; Craig TJ
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
7. Current medical management of hereditary angioedema: results from a large survey of US physicians.
Riedl M; Gower RG; Chrvala CA
Ann Allergy Asthma Immunol; 2011 Apr; 106(4):316-322.e4. PubMed ID: 21457880
[TBL] [Abstract][Full Text] [Related]
8. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hereditary angioedema: a review (CME).
Bhardwaj N; Craig TJ
Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
[TBL] [Abstract][Full Text] [Related]
10. A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom.
Yong PFK; Coulter T; El-Shanawany T; Garcez T; Hackett S; Jain R; Kiani-Alikhan S; Manson A; Noorani S; Stroud C; Symons C; Sargur R; Steele C; Alachkar H; Anantharachagan A; Arkwright PD; Bernatoniene J; Bhole M; Brown L; Buckland M; Burns S; Chopra C; Darroch J; Drewe E; Edmonds J; Ekbote A; Elkhalifa S; Goddard S; Grosse-Kreul D; Gurugama P; Hague R; Herriot R; Herwadkar A; Hughes SM; Jones L; Lear S; McDermott E; Kham Murng SH; Price A; Redenbaugh V; Richter A; Riordan A; Shackley F; Stichbury J; Springett D; Tarzi MD; Thomas M; Vijayadurai P; Worth A
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2476-2483. PubMed ID: 37146882
[TBL] [Abstract][Full Text] [Related]
11. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey.
Iwamoto K; Yamamoto B; Ohsawa I; Honda D; Horiuchi T; Tanaka A; Fukunaga A; Maehara J; Yamashita K; Akita T; Hide M
Allergol Int; 2021 Apr; 70(2):235-243. PubMed ID: 33168485
[TBL] [Abstract][Full Text] [Related]
13. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
Riedl MA; Danese M; Danese S; Ulloa J; Maetzel A; Audhya PK
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2450-2456.e6. PubMed ID: 36720386
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
16. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
Bernstein JA; Moellman JJ
Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
[TBL] [Abstract][Full Text] [Related]
17. Successful management of hereditary angioedema during tonsillectomy: a case report.
Hermans C; Vander Vorst S; Lambert C
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):155-7. PubMed ID: 22193715
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines for the diagnosis and treatment of hereditary angioedema].
Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
[TBL] [Abstract][Full Text] [Related]
19. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
Bernstein JA
Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema.
Nanda MK; Singh U; Wilmot J; Bernstein JA
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):198-203. PubMed ID: 24928306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
